US Patent Issued to Corxel Pharmaceuticals Hong Kong on July 15 for "Metalloenzyme inhibitor compounds" (North Carolina Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,893, issued on July 15, was assigned to Corxel Pharmaceuticals Hong Kong Ltd. (Causeway Bay, Hong Kong).

"Metalloenzyme inhibitor compounds" was invented by Steven Sparks (Apex, N.C.) and Christopher M. Yates (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes."

The patent was filed on Jan. 8, 2020, under Application No. 17/421,567.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=...